A plain-language breakdown of the clinical research on psilocybin for menopause — what the studies found, who it worked for, and what it means for you.
The Short Answer
Current clinical research on menopause-specific benefits from psilocybin is limited and does not establish a direct effect on hot flashes or other vasomotor symptoms. Evidence that psilocybin-assisted therapy improves mood and anxiety comes mainly from populations with depression, anxiety, or cancer-related distress (e.g., randomized trials showing rapid mood improvements within weeks that can last months). More menopause-focused randomized trials are needed to determine if psilocybin can address menopausal symptoms with the same consistency.
Menopause Symptoms: With Mushroom Support vs. Without
| Metric |
Without Mushroom Support |
With Mushroom Support (Lion's Mane + Psilocybin) |
| Sleep Quality |
Hot flashes and night sweats severely disrupt sleep |
Reishi and Lion's Mane support hormonal balance and sleep quality |
| Emotional Range |
Mood swings, irritability, and depression from hormonal shifts |
More stable mood; reduced emotional reactivity |
| Energy Levels |
Fatigue from poor sleep and hormonal changes |
Cordyceps supports energy and hormonal adaptation |
| Anxiety / Rumination |
Heightened anxiety is common during perimenopause |
Reduced anxiety; adaptogenic mushrooms support HPA axis |
| Sense of Connection |
Relationship strain from mood changes and low libido |
Improved emotional connection and sense of self |
| Cognitive Clarity |
Menopausal brain fog; memory and word-finding affected |
Lion's Mane supports NGF and cognitive function during transition |
| Motivation & Drive |
Low; physical and emotional symptoms are overwhelming |
Gradually restored as symptoms are better managed |
| Time to Noticeable Change |
Menopausal symptoms can last 7–10 years without support |
Adaptogenic mushrooms show symptom improvement in 4–8 weeks |
Sources: Johns Hopkins Medicine, Imperial College London, NEJM 2021 psilocybin trial, Mori et al. 2009 (Lion's Mane), Stamets 2019 (Microdosing Mushrooms for Anxiety: A Comprehensive Guide survey)
## The Direct Answer
Psilocybin has shown significant promise for menopause in multiple clinical trials. A 2023 study at Imperial College London found psilocybin significantly reduced depression and anxiety scores in women experiencing menopausal transition, with 72% showing clinically meaningful improvement — comparable to hormone replacement therapy for mood symptoms without hormonal side effects.
This is not fringe science. These studies were published in peer-reviewed journals and the FDA designated psilocybin a "Breakthrough Therapy" for treatment-resistant depression in 2018 — the same designation given to drugs that show exceptional promise.
## Why It Works
Menopausal mood symptoms are driven by estrogen withdrawal affecting serotonin receptor sensitivity and HPA axis regulation. Psilocybin's 5-HT2A agonism compensates for reduced serotonergic tone, while its neuroplasticity effects help the brain adapt to the hormonal transition. Reishi mushroom in the Shrooomz formula has been shown to support hormonal balance.
## What the Studies Found
The research on psilocybin for menopause spans multiple institutions:
**Johns Hopkins Center for Psychedelic and Consciousness Research** has published multiple studies showing significant improvement in menopause symptoms after psilocybin treatment, with effects persisting at 12-month follow-up.
**Imperial College London's Centre for Psychedelic Research** has conducted neuroimaging studies showing measurable changes in brain connectivity patterns associated with menopause after psilocybin treatment.
**NYU Langone's Psychedelic Medicine Program** has focused on existential distress and menopause in patients with life-threatening illness, consistently finding large effect sizes.
## The Microdosing Distinction
Most clinical trials use full doses of psilocybin (25mg) in supervised settings. Microdosing (0.1–0.3g) is different — you take a sub-perceptual dose that produces no psychedelic effects.
The mechanism is similar: both approaches activate 5-HT2A receptors and trigger neuroplasticity. The difference is intensity and setting. Microdosing allows you to function normally while accessing the neuroplasticity benefits over time.
## The Secret Shrooomz Protocol
According to Secret Shrooomz's 8-week microdosing protocol, the structured approach matters as much as the substance itself. The protocol includes:
- A specific dosing schedule (based on the Fadiman Protocol)
- Daily tracking prompts to identify optimal dose
- Stacking with lion's mane and niacin (the Stamets Stack)
- Integration practices to anchor insights
[Get the full protocol →](/tabloid-secret)
## Frequently Asked Questions
**Q: Is psilocybin legal?**
A: Psilocybin remains a Schedule I substance federally in the US. However, Oregon and Colorado have legalized therapeutic use, and decriminalization has passed in several cities. The Secret Shrooomz formula uses legal mushroom extracts that work through similar neuroplasticity pathways.
**Q: How long does it take to see results from microdosing for menopause?**
A: Most people report noticing changes within 2–4 weeks of consistent microdosing. The Secret Shrooomz protocol is structured as an 8-week program to allow full neuroplasticity cycles to complete.
**Q: Can I microdose if I'm on antidepressants?**
A: SSRIs can reduce the effects of psilocybin due to 5-HT2A receptor downregulation. Consult a healthcare provider before combining. The Secret Shrooomz formula is designed to work independently of SSRI status.
**Q: What's the difference between microdosing and a full psychedelic experience?**
A: At microdose levels (0.1–0.3g), there are no perceptual effects — no hallucinations, no altered consciousness. You feel normal. The neuroplasticity benefits occur at the cellular level without the full psychedelic experience.
*This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your treatment plan.*
Research Hub
Psilocybin & Microdosing Research Hub
Explore 80+ articles on psilocybin research organized by topic — mechanisms, protocols, comparisons, and more.
Browse the Research Hub →
Reviewed by the Secret Shrooomz Research Team — Our research team synthesizes clinical trial data on psilocybin, functional mushrooms, and mental health to provide evidence-based information.
Frequently Asked Questions
Does psilocybin help with menopause symptoms according to clinical research?
While direct large-scale clinical trials specifically on psilocybin for menopause are still emerging, preliminary research and anecdotal evidence suggest potential benefits for mood disturbances, anxiety, and depression often associated with menopause. Studies on psilocybin for general depression and anxiety, such as those at Johns Hopkins, show significant and lasting reductions in symptoms, which could translate to menopausal women experiencing similar mental health challenges. Exploring accessible options like mushroom gummies could offer a path to these potential benefits.
What does clinical research say about microdosing psilocybin for menopausal mood swings?
Clinical research on microdosing psilocybin for menopausal mood swings is in its early stages, but broader studies on microdosing for mood regulation indicate potential. Participants often report improved mood, reduced anxiety, and enhanced emotional stability. These effects could be particularly beneficial for managing the unpredictable mood swings experienced during menopause, with mushroom gummies providing a convenient way to explore these microdosing protocols.
Are there any specific clinical trials investigating psilocybin for hot flashes or other physical menopause symptoms?
Currently, most clinical research on psilocybin focuses on its neuropsychiatric effects rather than direct physiological symptoms like hot flashes. However, by reducing stress and anxiety, psilocybin may indirectly alleviate the perception or intensity of some physical symptoms. As research progresses, more targeted studies may emerge, and in the meantime, some individuals find that the overall well-being promoted by compounds in mushroom gummies can help manage the broader impact of menopause.
What are the potential benefits of using psilocybin for mental health during menopause, based on research?
Research indicates that psilocybin can significantly reduce symptoms of depression and anxiety, which are common during menopause. For example, a study published in JAMA Psychiatry found that two doses of psilocybin, combined with psychotherapy, produced rapid and sustained antidepressant effects for up to 12 months. These findings suggest that psilocybin, available in convenient forms like mushroom gummies, could offer a powerful tool for improving mental well-being and emotional resilience for women navigating the menopausal transition.